Sareum Holdings PLC (LSE:SAR) - Share price - Overview

Stock Report

Sareum Holdings PLC SAR

Last Price
GBX0.88

Day Change
0.00|0.00%

As of 26/05/2017
16:22:44 BST | GBX
Minimum 15 Minutes Delay.

Last Close0.88p
Day Range0.87 - 0.90
Mkt Cap23.28Mil
52-Wk Range0.56 - 1.73
Yield %0.00
ISINGB00B02RFS12
Volume2,788,385
P/E-32.41
P/SInfinity
P/CF-32.41

Share Price

Total Returns 26/05/2017

 Chg (%)  
More ...
Sareum Holdings PLC0.00 
FTSE 100 TR GBP4.15
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-0.84-1.31-1.21
Net Profit-0.76-1.26-1.05
Reported EPS-0.05-0.06-0.04
Balance Sheet
Current Assets1.081.721.49
Non Current Assets0.710.210.48
Total Assets1.791.931.96
Current Liabilities0.070.070.10
Total Liabilities0.070.070.10
Total Equity1.721.861.86
Cash Flow
Operating Cash Flow-0.84-0.72-0.86
Net Change in Cash0.280.78-0.23
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20170.240.02-55.00---
2018-0.50-0.02--44.00---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
08/03/2017PurchaseDr. Stephen Parker0.95461,9494,389.00
08/03/2017PurchaseDr. Stephen Parker0.95674,2726,406.00

Company Profile

Sareum Holdings PLC is a specialist drug discovery and development company. The Company is engaged in the discovery and development of new therapeutic drugs by a combination of skills in biology, computational chemistry and medicinal chemistry.

Sector

Drug Manufacturers - Major

Market Position

1325 of 1851 Companies

Index

FTSE AIM All Share

Outlook

(20/02/2017) "...we expect to end the current financial year with a modest profit"

Next Event 30/06/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-53.1815.0716.87
Div Yld (E)0.003.604.05
PEG (E)0.000.420.72
ROCE-46.65187.8415.97
Op Mrgn0.00-6.501.61
EPS Grwth0.0056.9427.17
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Stephen Parker
Chief Executive OfficerDr. Tim Mitchell
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.